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tant player in chondrocyte growth and differentiation. Regulation
by methylation which is the most common DNA modiﬁcation
remains unknown for arthrotic cartilage.
The aim of this study was to evaluate the inﬂuence of demethy-
lation on the gene expression of MMP - 13, BMP-2, Fli-1, Aggre-
cane, BMP-4 and collagen X.
Methods: We collected eight probes of human cartilage before
undergoing total knee joint replacement under sterile conditions
from osteoarthritis patients (5 female, 3 male). The average
patient’s age was 70 years (min 54, max 83). After digestion, the
cells were spread out and half of them were treated with 10 uM
of demethylation agent 5-AZA-deoxy-cytidine over a period of six
days. After harvesting the cells, RNA was extracted using the
Trizol method and cDNA was transcribed. Gene expression for
MMP-13, BMP-2, BMP-4, Aggrecane, Fli-1 and collagen X was
performed with the Taqman Realtime PCR Assay.
Results: Interestingly there was a remakable increase (4-fold)
of the gene expression of MMP-13 and a 1, 5-fold increase
of BMP-2 gene expression after treatment with 5-Aza-deoxy-
cytidine in the human arthrotic cartilage cell cultures compared
to the untreated controls. There was no obvious change in gene
expression for BMP-4, collagen X, Fli-1 and Aggrecane.
Conclusions: Further investigations are needed to show if
methylation plays a major role in regulating this pro-arthrotic
enzyme. If so this may lead us to new therapeutic aspects of
Osteoarthritis in the future.
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Purpose: Osteoarthritis (OA) is a joint disease characterized by
a degenerative change of articular cartilage and underlying sub-
chondral bone and often accompanied by inﬂammation. MSM,
a dietary supplement composed of about 34% sulfur and self-
afﬁrmed as GRAS (generally recognized as safe) in the U.S.,
is most utilized for treating osteoarthritis. A recent study by Kim
et. al., OA & Cart, 2006, showed clinical effectiveness of MSM
supplementation at 3 gm BID x 12 weeks compared to placebo.
The objective of our study was to examine the effect of MSM
at varying concentrations on cultured human healthy and os-
teoarthritic chondrocytes in vitro with a focus on catabolic and
anabolic markers.
Methods: Human cartilage tissues were obtained from 22 knees,
72 hrs postmortem from donors with different grades of OA. We
used the Outerbridge classiﬁcation (Grades I - IV), Grade I for
intact surface; Grade II for minimal ﬁbrillation; Grade III for overt
ﬁbrillation; and Grade IV for erosion of the articular cartilage
surface. Following gross assessment of the donor knees, the
following knees were studied for Grade I (n=6) (aged 23-38);
Grade II (n=9) (aged 50-77); for Grade III (n=5) (aged 32-70);
and Grade IV (n=2) (aged 70-93). Cartilage tissues were har-
vested from femoral condyles and tibial plateaus, the matrix was
dissolved with collagenase; the chondrocytes were then cultured
for 2 weeks in culture media without MSM. After reaching con-
ﬂuence, the chondrocytes were harvested and 2 x 105 cells in
10 ml culture medium with varying concentrations of MSM (0, 1,
3, 6, 12, and 60 µg/ml) were cultured in 100 mm (in-diameter)
plates at 37°C in 5% CO2 for 3 days. The concentrations were
estimated to correspond to human, oral dosing at between 0
and 30 grams of MSM per day. mRNA expression of various
markers by RT-PCR including: TNF-alpha, IL-1, MMP-1, MMP-3,
and MMP-13 was also determined for each OA grade and each
concentration of MSM or control. Anabolic pathways examined
included proteoglycan synthesis (by a pulse chase analysis of
35SO4 incorporation) and chondrocyte mRNA expressions of
Type-II collagen and aggrecan. A one-way ANOVA was per-
formed to establish the level of statistical signiﬁcance.
Results: In Grade II OA chondrocytes treated with MSM at the
concentration of 12 µg/ml, there was a strong trend for MSM
to reduce the mRNA expression of inﬂammatory markers: TNF-
alpha (-33%, p=0.08) and IL-1 (-29%, p=0.08) when compared to
lower concentrations of MSM and control. These results did not
apply for OA chondrocytes of Grade III or IV. MSM did not show
an increase in proteoglycan synthesis in cultured chondrocytes
or an increase of cartilage matrix production in normal and
osteoarthritic chondrocytes at the mRNA level.
Conclusions: MSM might have an ability to protect articular
cartilage in early OA by reducing expression of inﬂammatory cy-
tokines, i.e. TNF-alpha & IL-1. The effective concentration of 12
µg/ml MSM correlates with the dosage used in a recent clinical
trial. MSM did not elicit an anabolic response in this study.
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Purpose: Joint bleeds occur as a result of joint trauma or major
joint surgery. These joint bleeds, or haemarthroses, have a direct
devastating effect on the matrix turnover of articular cartilage,
which is due to apoptosis of the chondrocytes, as we have pre-
viously shown. Also the synovium is affected by the joint bleeds.
The synovium clears the blood from the joint, which leads to
haemosiderin deposition and successive synovial inﬂammatory
activities. This adds to the cartilage damage via the production
of pro-inﬂammatory - and tissue destructive mediators.
Recently we showed that relatively low concentrations of blood
present for a short period of time already lead to long-lasting
damage of human articular cartilage when determined in vitro.
The present study was undertaken to determine whether in vivo
these negative effects occur as rapid as determined in vitro.
Methods: Autologous blood was injected into the knee joint of
Beagle dogs, either 48 hours, 24 hours or 15 minutes before
termination. The amount of red and white blood cells present in
the joint cavity at the time of termination were determined. The
proteoglycan synthesis rate and release of the cartilage were
determined. Furthermore the cartilage destructive properties of
the synovial tissue were tested by measuring the proteoglycan
synthesis rate, -release and -content of healthy cartilage after
exposure to culture supernatants of synovial tissue from the
blood-exposed joints. All results were compared to the values of
the uninjected joint.
Results: Fifteen minutes after the injection of autologous blood,
the red blood cell count was 67*1012/L, comparable to the amount
present in whole blood, and gradually decreased (50% at 24
hours) to 6,7*1012/L within 48 hours (<10%). The amount of
white blood cells increased in the ﬁrst 24 hours, and was still
increased after 48 hours, although less than after 24 hours.
The proteoglycan synthesis rate and -release were adversely
affected already within 24 hours (-15% and +23% respectively),
and these effects were more severe 48 hours post-injection
(-31% and +32% resp.). Synovial tissue culture supernatants
